Indonesian police said on Monday a local trader of industrial-grade chemicals sold them as pharmaceutical-grade, leading to their use in medicated syrups that authorities suspect may have caused deaths of more than 200 children across the country.
Last year more than 300 children – mainly aged under 5 – died of acute kidney injury, deaths that were associated with contaminated medicines, the WHO said in a statement.
Indonesian authorities aim to give the shots to 1.4 million girls next year, the company said, adding it aimed to produce 2.8 million doses given the two-shot regime recommended to inoculate against HPV-linked cervical cancer.
The FDA granted priority review to Takeda’s Biologics License Application for TAK-003, a dengue vaccine candidate. The vaccine to date is only approved for use in Indonesia.
The Southeast Asian country temporarily banned sales of some syrup-based medications in October after it identified the presence in some products of ethylene glycol and diethylene glycol as possible factors for causing the illness.
Gambia has not yet confirmed that toxic cough syrup was the cause of the deaths of 70 children from acute kidney injury, a representative of the country’s Medicines Control Agency said on Monday.
Indonesia’s food and drug agency (BPOM) said on Monday it had revoked licenses of syrup-type drug production of two local firms for violating manufacturing rules, as it probes the deaths of more than 150 children due to acute kidney injury (AKI).
Global deaths from tuberculosis are estimated to have increased between 2019 and 2021, reversing years of decline as the COVID-19 pandemic severely derailed efforts to tackle the disease, the World Health Organization said on Thursday.
Indonesia’s food and drugs agency on Monday said it may pursue criminal action against two pharmaceutical firms that made products linked to acute kidney injury (AKI), amid a spike in cases and deaths among children this year.
Indonesia’s health minister said on Friday that the number of children who had died from acute kidney injury (AKI) rose to 133 from the previously reported 99.